MRSN vs VZ · rev $40.5M vs P/E 11, rev $34.25B
Mersana Therapeutics Inc (MRSN) versus Verizon Communications Inc (VZ) — a side-by-side from cached financials, not a winner call.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Verizon Communications Inc (VZ) is a telecom services company listed on NYSE. It is led by Hans Vestberg.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
Latest reported VZ revenue for 2026-06-30 was $34.25B. Net income was $3.83B. Revenue was down 0.5% from 2026-03-31 to 2026-06-30. VZ currently screens at market cap $191.41B and trailing P/E 11.2.
MRSN currently screens at market cap $145.4M. VZ currently screens at market cap $191.41B and trailing P/E 11.2.
Not investment advice. Open the MRSN and VZ stock pages for the full models.
Not investment advice.